|
|
||||||||
,
,
* Epithelial Pathobiology Division, Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322;
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and
Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Kawaguchi, Japan
Epithelial cells detect motile pathogens via TLR5 ligation of flagellin, resulting in rapid induction of antibacterial/proinflammatory gene expression. Although such flagellin-induced gene expression is quite transient, likely to avoid the negative consequences of inflammation, little is known regarding the molecular mechanisms that mediate its shutdown. We hypothesized that, analogous to the case for TLR4, phosphoinositide 3-kinase (PI3K) might negatively regulate TLR5 signaling. However, because PI3K is an essential positive mediator of some pathways of TLR-mediated gene expression, the opposite hypothesis was also considered. Herein, we observed that flagellin stimulation of epithelial cells indeed induced rapid (<30 min) PI3K activation, as evidenced by Akt phosphorylation, via a TLR5-mediated mechanism. Blockade of PI3K with wortmannin resulted in marked enhancement of flagellin-induced gene expression as assessed by measuring levels of inducible NO synthase, IL-6, and IL-8. Such enhancement of gene expression by PI3K inhibition correlated with prolonged activation of MAPK (p38 and ERK1/2) and was ablated under MAPK inhibition. Such effect of inhibiting PI3K with wortmannin was mimicked by the PI3K inhibitor LY294002, and, conversely, a constitutively active PI3K prevented p38 activation in response to flagellin. Last, to test the significance of these results in vivo, we measured flagellin-induced gene expression in PI3K knockout mice. PI3K-null mice displayed increased levels of flagellin-induced serum IL-6, KC (IL-8 homolog), and nitrite as compared with heterozygous littermates. Thus, TLR5s rapid activation of PI3K serves to limit MAPK signaling, thus limiting proinflammatory gene expression and reducing the potential negative consequences of proinflammatory gene expression.
This article has been cited by other articles:
![]() |
A. W. Boots, M. Hristova, D. I. Kasahara, G. R. M. M. Haenen, A. Bast, and A. van der Vliet ATP-mediated Activation of the NADPH Oxidase DUOX1 Mediates Airway Epithelial Responses to Bacterial Stimuli J. Biol. Chem., June 26, 2009; 284(26): 17858 - 17867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. W. Laird, S. H. Rhee, D. J. Perkins, A. E. Medvedev, W. Piao, M. J. Fenton, and S. N. Vogel TLR4/MyD88/PI3K interactions regulate TLR4 signaling J. Leukoc. Biol., June 1, 2009; 85(6): 966 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. W. Walton, L. Holt, and R. B. Sartor Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G601 - G611. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Snoeks, C. R. Weber, J. R. Turner, M. Bhattacharyya, K. Wasland, and S. D. Savkovic Tumor Suppressor Foxo3a Is Involved in the Regulation of Lipopolysaccharide-Induced Interleukin-8 in Intestinal HT-29 Cells Infect. Immun., October 1, 2008; 76(10): 4677 - 4685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohtani, S. Nagai, S. Kondo, S. Mizuno, K. Nakamura, M. Tanabe, T. Takeuchi, S. Matsuda, and S. Koyasu Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells Blood, August 1, 2008; 112(3): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Calippe, V. Douin-Echinard, M. Laffargue, H. Laurell, V. Rana-Poussine, B. Pipy, J.-C. Guery, F. Bayard, J.-F. Arnal, and P. Gourdy Chronic Estradiol Administration In Vivo Promotes the Proinflammatory Response of Macrophages to TLR4 Activation: Involvement of the Phosphatidylinositol 3-Kinase Pathway J. Immunol., June 15, 2008; 180(12): 7980 - 7988. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Burdelya, V. I. Krivokrysenko, T. C. Tallant, E. Strom, A. S. Gleiberman, D. Gupta, O. V. Kurnasov, F. L. Fort, A. L. Osterman, J. A. DiDonato, et al. An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models Science, April 11, 2008; 320(5873): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ueno, T. Koga, K. Kato, D. T. Golenbock, S. J. Gendler, H. Kai, and K. C. Kim MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 263 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kato, W. Lu, H. Kai, and K. C. Kim Phosphoinositide 3-kinase is activated by MUC1 but not responsible for MUC1-induced suppression of Toll-like receptor 5 signaling Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L686 - L692. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Feuillet, S. Medjane, I. Mondor, O. Demaria, P. P. Pagni, J. E. Galan, R. A. Flavell, and L. Alexopoulou Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria PNAS, August 15, 2006; 103(33): 12487 - 12492. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |